Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States

A. SUD ; K. CHIU ; J. FRIEDMAN ; J. DUPOUY | 2023
Dans International Journal of Drug Policy (Vol.120, October 2023) Article : Périodique

Background: In passing the Maintstreaming Addiction Treatment Act, the United States has abolished its federal X waiver, considered a major barrier to the wider buprenorphine prescribing needed to respond to opioid-related harms. Advocates for t[...]

Plus d'info

Ajouter à la sélection

Lien externe